MEDBOT-B, also known as MicroPort Robotics-B, saw its stock price plummet 5.04% during intraday trading. The sharp decline reflected heightened selling pressure and negative sentiment surrounding the company.

The drop was driven by significant institutional selling, with Hillhouse Capital entities notably reducing their holdings in the company. Market concerns also persisted regarding the potential for parent company MicroPort Medical to divest its robotics business equity to address cash flow constraints, adding to investor anxiety.

Furthermore, the company's ongoing loss-making stage with a negative price-to-earnings ratio intensified risk-averse sentiment. The broader Health Care Equipment sector's continued weakness further amplified the stock's decline, creating a challenging environment for MEDBOT-B.